January 11, 2010 - Interventional radiologists at Baptist Health Medical Center - Little Rock, Ark., recently became one of the first physicians in the U.S. to performed a technique, which uses an electric current instead of heat or freezing to permanently open cell membrane pores in the tumor, using irreversible electroporation (IRE). The IRE method does not require any chemotherapy.

Doctors were able to apply the technique using a new image-guided interventional NanoKnife to treat a malignant nodule within the lung. The system delivers electricity to the target cells. Once the cell membrane pores are opened, the tumor cells begin to die. The interventional radiologist uses imaging-guidance ultrasound or computed tomography (CT) imaging to insert probes into the tumor area. When the NanoKnife probes are in place, the physician then delivers high-voltage electrical pulses through the tumor. The tumor cells receiving the electrical pulses will open their microscopic pores permanently, which ultimately causes the cells to die, dissolve and be removed by the body’s natural processes.

"IRE is a remarkable new minimally-invasive cancer treatment that kills tumors in a completely new way," said David Hays, M.D., section chief, Interventional Radiology Department at Baptist Health. "The tumor cells are killed, but the surrounding framework of the organ is left intact. IRE expands our options for interventional oncology treatments and further enables our collaboration with medical professionals to provide the best possible treatment for our patients with cancer."

David Hays, M.D., indicated that electroporation had been used before to temporarily open tumor cells, allowing chemotherapy to enter individual cells and kill them from the inside, but the IRE method does not require any chemotherapy. “Using the NanoKnife during an IRE procedure allows us to be more precise and much faster and causes less damage to normal surrounding structures,” said Dr. Hays.

The NanoKnife was recently approved by the U.S. Food and Drug Administration for surgical ablation of soft tissue and is manufactured by AngioDynamics.

For more information: www.baptist-health.com.


Related Content

News | FDA

Nov. 26, 2025 — a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and ...

Time December 03, 2025
arrow
News | RSNA 2025

Nov. 13, 2025 — Nano-X Imaging Ltd., a medical imaging technology company, will showcase its Nanox.ARC X multi-source ...

Time November 25, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
Feature | Teleradiology | Kyle Hardner

Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...

Time November 06, 2025
arrow
News | RSNA 2025

Oct. 31, 2025 — Echolight plans to demonstrate its bone density scanning technology at the Radiological Society of North ...

Time November 03, 2025
arrow
Subscribe Now